Arkolith/Insider Trading/STOK/Form 4

Leggett Thomas

Chief Financial OfficerStoke Therapeutics, Inc. (STOK) · full profile →Form 4 · filed Mar 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$147K
Net Open-Market Flow
-$147K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2026Sell(S)37$32.85$1K10K
Mar 18, 2026Sell(S)172$31.79$5K10K
Mar 18, 2026Sell(S)2K$31.28$68K10K
Mar 17, 2026Sell(S)922$33.38$31K13K
Mar 17, 2026Sell(S)1K$32.74$42K13K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001774690-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML